Skip to main content

Table 1 Characteristics of the 200 FCV-suspect and the 100 healthy cats. The cats originated from 19 different cantons in Switzerland

From: Feline calicivirus and other respiratory pathogens in cats with Feline calicivirus-related symptoms and in clinically healthy cats in Switzerland

Parameter

FCV-suspect cats (n = 200)

Healthy cats (n = 100)

 

Median

Lower 95 % CIa

Upper 95 % CIa

Median

Lower 95 % CIa

Upper 95 % CIa

Age (years)

4

0.20

16

0.75

0.3

14.8

 

Proportion

Lower 95 % CIa

Upper 95 % CIa

Proportion

Lower 95 % CIa

Upper 95 % CIa

Sex (male)

0.60

0.52

0.66

0.61

0.51

0.71

Intact reproductive status

0.37

0.30

0.44

0.40

0.30

0.50

Pedigree

0.32

0.25

0.39

0.22

0.14

0.32

Breedbc

      

 Maine Coon

0.09

0.05

0.14

0.02

0.01

0.07

 British Shorthair

0.05

0.02

0.09

0.02

0.01

0.07

 Norwegian Forest Cat

0.05

0.02

0.09

0.02

0.01

0.07

 Persian

0.04

0.02

0.08

0.04

0.01

0.1

 Siamese

0.03

0.01

0.06

0.02

0.01

0.07

Multi-cat household

0.72

0.65

0.78

0.63

0.53

0.72

Group housing with ≥ 4 cats

0.22

0.16

0.29

0.16

0.09

0.25

Outdoor access

0.57

0.50

0.64

0.58

0.48

0.68

Contact with dog with kennel coughc

0.02

0

0.05

0.01

0

0.06

Vaccinated

0.76

0.69

0.82

0.80

0.70

0.87

Primary immunizationd

0.69

0.61

0.75

0.72

0.61

0.81

Immunosuppressive therapy

0.15

0.10

0.20

0.01

0.00

0.05

Antibiotic therapy

0.42

0.35

0.49

0.02

0.00

0.07

Antiviral therapy

0.05

0.02

0.08

0.00

0.00

0.04

FCV positivee

0.45

0.38

0.52

0.08

0.04

0.15

M. felis positivee

0.48

0.41

0.55

0.31

0.22

0.41

FHV-1 positivee

0.20

0.15

0.26

0.09

0.04

0.16

C. felis positivee

0.08

0.05

0.13

0.01

0.00

0.05

B. bronchiseptica positivee

0.04

0.02

0.08

0.02

0.00

0.07

  1. aCI = Confidence interval. bOnly breeds with >5 cats in the study are listed. cDue to low numbers, these variables were not considered in the statistical analysis. dPrimary immunization was defined as two subsequent vaccinations within 2 to 6 weeks with the same vaccine strain. ePositive by real-time qPCR/RT-qPCR